RSV Diagnostic Market

RSV Diagnostic Market Size, Share & Trends Analysis Report By Type (Kits, Instruments, Others), By Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), By End-User (Hospitals – clinics, Clinical labs, Home care), Region, And Segment Forecasts, 2021 - 2027

  • Report ID: BMRC 1592 | Number of pages: 198 | Published Date: May 2021
    Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On RSV Diagnostic Market Size, Share & Trends Analysis Report By Type (Kits, Instruments, Others), By Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), By End-User (Hospitals – clinics, Clinical labs, Home care), Region, And Segment Forecasts, 2021 - 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Global RSV Diagnostic Market is valued at USD 767.8 Million in 2020 and expected to reach USD 1465.1 Million by 2027 with a CAGR of 9.67% over the forecast period.

Global Respiratory Syncytial Virus (RSV) Diagnostic Market: Global Size, Trends, Competitive, Historical Forecast Analysis, 2021-2027- Factors like increasing prevalence of respiratory diseases, growing demand of POC test kits, and increasing cases of pneumonia like disease in infants or in geriatric population driving the growth of the market.

Scope of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:

Respiratory syncytial virus is a very common and contagious virus which infects respiratory track of most children before 1-2 year of their age. RSV was discovered from chimpanzee BY J. Morris and associate in 1956. RSV is an enveloped RNA virus of family Paramyxoviridae which causes lung infections. It affects all generations but it is very dangerous for infants and older infants. RSV is most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults and it can occasionally causes serious infection that needs hospitalization from breathing compromise with bronchiolitis or pneumonia. In most of the people, symptoms usually develops after 4-6 days of exposure to RSV which is known as incubation period of RSV virus. Symptoms of RSV includes runny nose, loss of appetite followed by coughing or sneezing or mild fever. Also in infants sometimes develop serious symptoms like wheezing, irritability, cyanosis and breathing difficulties. RSV spreads person to person via coughing or sneezing. For diagnosis, mostly doctors use blood or urine test to look for a bacterial infection, chest x-ray for checking any signs of pneumonia, test of material scraped out from persons nose or, mouth. In treatment of RSV of infants doctors uses cool mist vaporizer to keep the air moist and make breathing easier. Also non aspirin fever reducer tablets are used. In serious cases, doctors use IV fluid or medications to open the air ways.

Covid-19 has shown a positive impact on the growth of global RSV diagnostics market owing to the increasing prevalence of Covid-19 cases which is also a respiratory diseases. And RSV is also a contagious respiratory infection. Thus, some of the players are offering and producing RSV diagnostic kits with combination to Covid-19 testing. For example; on January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample.

The regions covered in this Global RSV diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of RSV diagnostic is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Top Companies:

Key players of Global Respiratory Syncytial Virus (RSV) Diagnostic Market:

Some major key players of global RSV diagnostics market are Becton, Dickinson and Company, Novartis diagnostics, Abbott laboratories, ortho clinical diagnostics, Thermo fisher scientific inc., Bio-rad laboratories inc., Hoffmann la Roche limited, Biomerieux, Diasorin spa, Emd millipore, Quidel corporation, Alere inc., Coris bioconcept, fast-track diagnostics, Quest diagnostics and others.

RSV Diagnostic

News:

New All-in-One Test for COVID-19/Flu/RSV

On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample. The TCA/GENETWORx Flu A-B/COVID Combo Test is a molecular diagnostic PCR test that detects two types of influenza viruses; influenza A and B and differentiates them from RSV, and SARS-CoV-2, the virus that causes COVID-19. The Flu A-B/COVID Combo Test provided by GENETWORx has a 98% accuracy rate for influenza, 99% for COVID-19, and 96% for RSV.

Increasing Prevalence of Respiratory Diseases and Rising Prevalence of Covid-19 Cases are the Major Factors Driving the Market Growth

Increasing prevalence of respiratory diseases, growing demand of POC test kits and increasing cases of pneumonia like disease in infants or in geriatric population driving the growth of the market. For example; according to American Lung Association, infants have high risk of developing RSV. About 5%-10% infants are getting affected by RSV and 25%-40% people having bronchitis and pneumonia have chances to develop RSV in them. This respiratory syncytial virus can passes from one person to other. It enters the body through the eyes, nose or mouth. This virus can infect people by coughing or sneezing and also from shaking hands. In addition, growing demand of POC test for diagnosis of RSV infections is also propelling the growth of the market. As main feature of POC testing is rapidity. It provides immediate information to physician about patients’ health condition. These tests are effective in case of RSV to check the infection. Therefore growing demand of POC test for diagnosis is propelling the growth of the market. Furthermore, increasing number of product offerings by key players is also fostering the market growth. For instance; in March 2020 Roche diagnostics launch cobas liat POC device. This device shows excellent analytical performance to detect influenza A, influenza B and RSV, and it is considered as easy to use. Also adults having chronic disorders or weak immune system have high risk of developing RSV.

However, lack of awareness among the parents about its diagnostics especially in rural areas may hamper the growth of the market. In spite of that, advancement in diagnostic technology can offer more opportunities for the further growth of the market.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD 767.8 Million 
Base year considered 2020
Forecast Period CAGR %:

9.67 %

Market Size Expected in 2027: USD 1465.1 Million 
Tables, Charts & Figures: 175
Pages 200
Key Players/Companies Becton, Dickinson and Company, Novartis diagnostics, Abbott laboratories, ortho clinical diagnostics, Thermo fisher scientific inc., Bio-rad laboratories inc., Hoffmann la Roche limited, Biomerieux, Diasorin spa, Emd millipore, Quidel corporation, Alere inc., Coris bioconcept, fast-track diagnostics, Quest diagnostics and others
Segments Covered By Type, By End-User, By Methods
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:

  • Global RSV Diagnostics Market report covers in-depth historical and forecast analysis.
  • Global RSV Diagnostics Market research report provides detail information about Market Introduction, Market Summary, Global market, Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global RSV Diagnostics Market report helps to identify opportunities in
  • Global RSV Diagnostics Market report covers extensive analysis of emerging trends and competitive.

Segmentation Analysis:

Global RSV diagnostic market is segmented on the basis of type, method, end user and regional & country level. On the basis of type, market is classified into kits, instruments and others. On the basis of method, market is classified into molecular diagnostics and rapid antigen detection tests. On the basis of end-user, the market is classified into hospitals, clinics, clinical labs and home care.

Global RSV Diagnostics Market Segmentation:-

By Type:

  • Kits
  • Instruments
  • Others

By Methods:

  • Molecular Diagnostics 
  • Rapid Antigen Detection Tests
  • Enzyme-Linked Immunosorbent Assays
  • Immunofluorescence Assays
  • Other Rapid Antigen Detection Tests

By End-User:

  • Hospitals, clinics
  • Clinical labs
  • Home care

Regional Analysis:

North America is Expected to Dominate the Global Respiratory Syncytial Virus (RSV) Diagnostics Market

The global RSV diagnostics market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global RSV diagnostics market within the forecast period due to increasing cases of RSV infection in this region. For instance; According to CDC (Centre for Disease Control and Prevention) it is estimated that more than 177,000 older adults are hospitalized and 14000 of them die in the US due to RSV infection. In addition, increasing number of product offerings by leading players is also fostering the market growth. For example; in 2020 Bio-Rad launched SARS-CoV-2, RSV positive and negative run controls for respiratory PCR assays in which SARS-CoV-2, RSV positive run control is made with whole organism SARS-COV2, influenza A, influenza B and RSV. This product is made with synthetic matrix and human genome.

Europe is projected to capture the significant share of global RSV market attributed to increase in adoption of POC test and rising cases of chronic respiratory diseases such as RSV in this region. For example; according to WHO it is estimatated that, 65 million people affected by moderate to severe chronic respiratory disease, from which 3 million people die each year.

Global Respiratory Syncytial Virus (RSV) Diagnostics Market By Regional & Country Level:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

Latin America

  • Brazil
  • Mexico


Frequently Asked Questions (FAQ) :
Global RSV Diagnostic Market is valued at USD 767.8 Million in 2020 and expected to reach USD 1465.1 Million by 2027 with a CAGR of 9.67% over the forecast period.
Becton, Dickinson and Company, Novartis diagnostics, Abbott laboratories, ortho clinical diagnostics, Thermo fisher scientific inc., Bio-rad laboratories inc., Hoffmann la Roche limited, Biomerieux, Diasorin spa, Emd millipore, Quidel corporation, Alere inc., Coris bioconcept, fast-track diagnostics, Quest diagnostics and others
Factors like increasing prevalence of respiratory diseases, growing demand of POC test kits, and increasing cases of pneumonia like disease in infants or in geriatric population driving the growth of the market
North America is expected to dominate the global RSV diagnostics market within the forecast period due to increasing cases of RSV infection in this region



Interested in this report?

RSV Diagnostic Market Size 2021 and Analysis 2019-2025

report cover

Request for Table of Content

RSV Diagnostic Market Size, Share & Trends Analysis Report By Type (Kits, Instruments, Others), By Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), By End-User (Hospitals – clinics, Clinical labs, Home care), Region, And Segment Forecasts, 2021 - 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.

    Pricing


+44-1173181773
vishal@brandessenceresearch.com


Looking for Regional Reports?